Steven Baldwin > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Steven Baldwin
Work Department
Intellectual Property Litigation
Position
Steven Baldwin is a partner in Kirkland’s IP Litigation team in London with significant experience representing clients in patent, life sciences regulatory, copyright, trademark and trade secrets matters. His practice focuses primarily on complex cross-border telecommunications (SEP/FRAND) and life sciences patent disputes and former employee trade secrets cases. Steven has developed a particular interest in, and deep knowledge of, the law governing supplementary protection certificates and is recognised as a thought leader and regular writer, speaker and commentator on the topic.
Steven’s case experience covers a broad range of technical fields including 3GPP, 3GPP2, DMR, TETRA and other wireless (standardised and non-standardised) mobile telecommunications technologies, organic chemistry, antibody biologics, biological product development and screening platforms, formulation science, next generation cancer treatments, and e-cigarette/vaping technologies.
Steven also has significant non-contentious IP experience including billion-dollar IP portfolio purchases, global strategic IP portfolio strategies, and business-critical licensing deals, as well as advising on image rights, sponsorship and global celebrity advertising campaigns for world-renowned soccer clubs and automotive clients.
Career
2018 to present Kirkland & Ellis International LLP; 2010-2018 Allen & Overy LLP
Memberships
The Law Society of England & Wales; AIPPI: International Association for the Protection of Intellectual Property
Education
University of Oxford (Postgraduate Diploma in Intellectual Property Law and Practice, 2013; B.A. Jurisprudence, 2008); College of Law (Legal Practice Course, 2009)
Lawyer Rankings
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
‘Top-class’ Kirkland & Ellis International LLP maintains a strong IP offering, routinely handling high-stakes disputes, one notable example being the team’s representation of Pfizer and Regeneron in landmark judgments in the Supreme Court. The team of ‘ferocious litigators’ also has experience of handling SEP/FRAND related litigation. On the transactional side, the team is involved in M&A deals, as well as multiple asset deals and carve-out transactions. Nicola Dagg spearheads the IP litigation practice, she has a wealth of experience in managing biotech patent litigations, as well as an expertise in emerging SEP/FRAND related work. Daniel Lim is noted for his ability to handle complex multijurisdictional patent litigation, often involving blockbuster life sciences and medical devices related matters, while IP litigator Steven Baldwin is well-versed in the high-tech and life sciences sectors. ‘Strategic thinker’ Jin Ooi fields a strong IP litigation practice, with his expertise in the biotechnology space. Emma Flett leads the firm’s technology and IP transactions team with her capabilities that encompass the full gamut of IP-related work, but especially in regard to high-value M&A transactions.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium